Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-01-03 @ 6:11 PM
Study NCT ID:
NCT03172494
Status:
COMPLETED
Last Update Posted:
2022-12-14
First Post:
2017-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-24
First Submit QC Date:
None
Study First Post Date:
2017-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-06-11
Results First Submit QC Date:
None
Results First Post Date:
2020-07-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-18
Last Update Post Date:
2022-12-14
Last Update Post Date Type:
ACTUAL